02196 FOSUN PHARMA
- 13.420
- +0.120+0.90%
FOSUN PHARMA News
Analysts Conflicted on These Healthcare Names: UnitedHealth (UNH), Shanghai Fosun Pharmaceutical (Group) Co (OtherSFOSF) and Entero Healthcare Solutions Limited (IN:ENTERO)
Shanghai Fosun Pharma Unit Starts Phase 2 Trial for Kidney Filtration System Disease Drug
Fosun Pharma Subsidiary Advances Drug for Glomerular Diseases
Fosun Pharmaceutical's Unit Gets China Nod for Registration of Breast Cancer Drug
Express News | Shanghai Fosun Pharma - Drug Registration Application for Fovinaciclib Citrate Capsules of Jinzhou Avanc Pharmaceutical Accepted by Nmpa
Here's Why Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Has A Meaningful Debt Burden
Shanghai Fosun Pharmaceutical (Group) Subsidiary's Cancer Drug's NDA Accepted by NMPA
Shanghai Fosun Pharma's New Cancer Drug Application Accepted
Shanghai Fosun Pharmaceutical Subsidiary Signs Cooperation, License Deal
Shanghai Fosun Pharma Moves Hong Kong Office
Regent Pacific's Strategic Partners Submits NDA for Premature Ejaculation Drug in China
Market Cool On Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s (SHSE:600196) Earnings
Shanghai Fosun Pharmaceutical Moves Forward With Henlius Merger
Fosun Pharmaceutical Buys Back Nearly 3 Million Yuan Worth of Shares
Fosun Pharma Boosts Equity in Key Funds
Express News | Shanghai Fosun Pharma - Ningbo Fuying Will Acquire Equity Interests of RMB200.00 of Fund
Shanghai Fosun Pharma's New Strategic Agreements With Fosun International
Shanghai Fosun Pharmaceutical Gets Drug Registration for Pertuzumab Biosimilar
Shanghai Fosun Pharmaceutical (Group)'s Blood Health Medication Gets NMPA's Nod
Shanghai Fosun Pharmaceutical (Group) Unit's Cervical Dystonia Gets NMPA Nod
No Data
